Market Tracker

05/02 4:03am ET

Arbutus Biopharma Corp (NASDAQ:ABUS)

4.95
Delayed Data
As of Apr 29
 -0.22 / -4.26%
Today’s Change
2.72
Today|||52-Week Range
16.41
+11.24%
Year-to-Date
No recent news for Arbutus Biopharma Corp.

Today’s Trading

Previous close5.17
Today’s open5.15
Day’s range4.80 - 5.16
Volume233,783
Average volume (3 months)236,654
Market cap$282.4M
Dividend yield--
Data as of 04/29/2016

Growth & Valuation

Earnings growth (last year)+25.56%
Earnings growth (this year)-22.95%
Earnings growth (next 5 years)+15.00%
Revenue growth (last year)+66.34%
P/E ratio--
Price/Sales8.13
Price/Book0.52

Competitors

 Today’s
change
Today’s
% change
ADXSAdvaxis Inc-0.57-6.86%
ARDXArdelyx Inc-0.04-0.50%
VSARVersartis Inc-0.67-6.89%
CMRXChimerix Inc-0.04-0.66%
Data as of 04/29/2016

Financials

Next reporting dateMay 10, 2016
EPS forecast (this quarter)-$0.39
Annual revenue (last year)$24.9M
Annual profit (last year)-$61.1M
Net profit margin-245.73%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Mark J. Murray
Chief Operating &
Business Officer
Patrick T. Higgins
Corporate headquarters
Burnaby, British Columbia

Forecasts